Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations.
Awada H, Kerr CM, Durmaz A, Adema V, Gurnari C, Pagliuca S, Zawit M, Kongkiatkamon S, Rogers HJ, Saunthararajah Y, Sekeres MA, Carraway H, Maciejewski JP, Visconte V. Awada H, et al. Among authors: saunthararajah y. Leukemia. 2021 Nov;35(11):3324-3328. doi: 10.1038/s41375-021-01176-7. Epub 2021 Feb 18. Leukemia. 2021. PMID: 33603144 Free PMC article. No abstract available.
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.
Kongkiatkamon S, Pagliuca S, Adema V, Nagata Y, Kerr CM, Walter W, Awada H, Hutter S, Gurnari C, Rogers HJ, Meggendorfer M, Saunthararajah Y, Haferlach T, Visconte V, Maciejewski JP. Kongkiatkamon S, et al. Among authors: saunthararajah y. Leukemia. 2022 Apr;36(4):1185-1188. doi: 10.1038/s41375-021-01479-9. Epub 2021 Nov 29. Leukemia. 2022. PMID: 34845315 No abstract available.
Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome.
Durrani J, Awada H, Kishtagari A, Visconte V, Kerr C, Adema V, Nagata Y, Kuzmanovic T, Hong S, Patel B, Nazha A, Lichtin A, Mukherjee S, Saunthararajah Y, Carraway H, Sekeres M, Maciejewski JP. Durrani J, et al. Among authors: saunthararajah y. Leukemia. 2020 Mar;34(3):957-962. doi: 10.1038/s41375-019-0601-y. Epub 2019 Oct 17. Leukemia. 2020. PMID: 31624375 Free PMC article. No abstract available.
Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia.
Adema V, Khouri J, Ni Y, Rogers HJ, Kerr CM, Awada H, Nagata Y, Kuzmanovic T, Advani AS, Gerds AT, Mukherjee S, Nazha A, Saunthararajah Y, Madanat Y, Patel BJ, Solé F, Nawrocki ST, Carew JS, Sekeres MA, Maciejewski JP, Visconte V, Carraway HE. Adema V, et al. Among authors: saunthararajah y. Leuk Lymphoma. 2021 Mar;62(3):735-738. doi: 10.1080/10428194.2020.1839647. Epub 2020 Nov 3. Leuk Lymphoma. 2021. PMID: 33140678 Free PMC article. No abstract available.
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.
Advani AS, Tiu R, Saunthararajah Y, Maciejewski J, Copelan EA, Sobecks R, Sekeres MA, Bates J, Rush ML, Tripp B, Salvado A, Noon E, Howard M, Jin T, Hsi E, Egorin MJ, Lim K, Cotta CV, Price C, Kalaycio M. Advani AS, et al. Among authors: saunthararajah y. Leuk Res. 2010 Dec;34(12):1622-6. doi: 10.1016/j.leukres.2010.03.021. Epub 2010 Apr 27. Leuk Res. 2010. PMID: 20427086 Clinical Trial.
Race and intensity of post-remission therapy in acute myeloid leukemia.
Brady AK, Fu AZ, Earl M, Kalaycio M, Advani A, Saunthararajah Y, Sobecks R, Copelan E, Sekeres MA. Brady AK, et al. Among authors: saunthararajah y. Leuk Res. 2011 Mar;35(3):346-50. doi: 10.1016/j.leukres.2010.07.020. Epub 2010 Aug 8. Leuk Res. 2011. PMID: 20696474
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV. Visconte V, et al. Among authors: saunthararajah y. Blood. 2012 Oct 18;120(16):3173-86. doi: 10.1182/blood-2012-05-430876. Epub 2012 Jul 23. Blood. 2012. PMID: 22826563 Free PMC article.
Successful use of very low dose subcutaneous decitabine to treat high-risk myelofibrosis with Sweet syndrome that was refractory to 5-azacitidine.
Liu Y, Tabarroki A, Billings S, Visconte V, Rogers HJ, Hasrouni E, Englehaupt R, Kalaycio M, Sekeres MA, Saunthararajah Y, Tiu RV. Liu Y, et al. Among authors: saunthararajah y. Leuk Lymphoma. 2014 Feb;55(2):447-9. doi: 10.3109/10428194.2013.802315. Epub 2013 Jun 24. Leuk Lymphoma. 2014. PMID: 23647061 No abstract available.
Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts.
Tabarroki A, Saunthararajah Y, Visconte V, Cinalli T, Colaluca K, Rogers HJ, Sekeres MA, Duong HK, Stein BL, Tiu RV. Tabarroki A, et al. Among authors: saunthararajah y. Leuk Lymphoma. 2015 Feb;56(2):497-9. doi: 10.3109/10428194.2014.916805. Epub 2014 May 27. Leuk Lymphoma. 2015. PMID: 24766471 No abstract available.
Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).
Visconte V, Tabarroki A, Zhang L, Hasrouni E, Gerace C, Frum R, Ai J, Advani AS, Duong HK, Kalaycio M, Saunthararajah Y, Sekeres MA, His ED, Shetty S, Rogers HJ, Tiu RV. Visconte V, et al. Among authors: saunthararajah y. Am J Hematol. 2014 Aug;89(8):862. doi: 10.1002/ajh.23755. Epub 2014 May 16. Am J Hematol. 2014. PMID: 24796269 Free article. No abstract available.
164 results